GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Institutional Ownership

Newron Pharmaceuticals SpA (XSWX:NWRN) Institutional Ownership : 4.11% (As of Apr. 29, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Newron Pharmaceuticals SpA's institutional ownership is 4.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Newron Pharmaceuticals SpA's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Newron Pharmaceuticals SpA's Float Percentage Of Total Shares Outstanding is 0.00%.


Newron Pharmaceuticals SpA Institutional Ownership Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Institutional Ownership Chart

Newron Pharmaceuticals SpA Historical Data

The historical data trend for Newron Pharmaceuticals SpA can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 3.98 4.02 4.03 4.07 4.03 4.01 4.02 4.17 4.27 4.11

Newron Pharmaceuticals SpA Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Newron Pharmaceuticals SpA (XSWX:NWRN) Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Patrick Langlois Supervisory Board

Newron Pharmaceuticals SpA (XSWX:NWRN) Headlines

No Headlines